Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PEGFILGRASTIM-CBQV: 732 Adverse Event Reports & Safety Profile

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
732
Total FAERS Reports
104 (14.2%)
Deaths Reported
94
Hospitalizations
732
As Primary/Secondary Suspect
3
Life-Threatening
2
Disabilities
Prescription
Status

FDA Application: 761039 ·

First Report: 20160101 · Latest Report: 20250826

What Are the Most Common PEGFILGRASTIM-CBQV Side Effects?

#1 Most Reported
Device malfunction
356 reports (48.6%)
#2 Most Reported
No adverse event
265 reports (36.2%)
#3 Most Reported
Death
76 reports (10.4%)

All PEGFILGRASTIM-CBQV Side Effects by Frequency

Side Effect Reports % of Total Deaths Hosp.
Device malfunction 356 48.6% 1 3
No adverse event 265 36.2% 0 0
Death 76 10.4% 76 4
Product dose omission issue 61 8.3% 3 5
Product label confusion 36 4.9% 0 1
Accidental exposure to product 29 4.0% 0 0
Neutrophil count decreased 18 2.5% 0 9
Bone pain 17 2.3% 0 2
Device failure 16 2.2% 0 1
Product packaging confusion 16 2.2% 0 0
Product quality issue 15 2.1% 0 1
Hospitalisation 14 1.9% 1 13
Device leakage 13 1.8% 0 0
Febrile neutropenia 13 1.8% 0 12
Drug ineffective 12 1.6% 0 6
Syringe issue 12 1.6% 0 0
Back pain 11 1.5% 3 6
Dyspnoea 11 1.5% 0 6
Nausea 11 1.5% 3 5
Neutropenia 11 1.5% 1 3

Who Reports PEGFILGRASTIM-CBQV Side Effects? Age & Gender Data

Gender: 60.3% female, 39.7% male. Average age: 55.2 years. Most reports from: US. View detailed demographics →

Is PEGFILGRASTIM-CBQV Getting Safer? Reports by Year

YearReportsDeathsHosp.
2016 1 0 0
2018 1 0 0
2019 56 5 25
2020 62 14 18
2021 31 15 7
2022 17 6 2
2023 8 4 0
2024 248 12 13
2025 140 3 2

View full timeline →

What Is PEGFILGRASTIM-CBQV Used For?

IndicationReports
Product used for unknown indication 409
Infection prophylaxis 62
Prophylaxis 57
Neutropenia 19
Pancreatic carcinoma 12
Agranulocytosis 8
Breast cancer 8
Chemotherapy 8
Febrile neutropenia 8
Breast cancer female 6

PEGFILGRASTIM-CBQV vs Alternatives: Which Is Safer?

PEGFILGRASTIM-CBQV vs PEGFILGRASTIM-JMDB PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2A OR PEGINTERFERON ALFA-2B OR PEGINTERFERON BETA-1A OR PEGINTERFERON LAMBDA-1A PEGFILGRASTIM-CBQV vs PEGINTERFERON ALFA-2B PEGFILGRASTIM-CBQV vs PEGINTERFERON BETA-1A PEGFILGRASTIM-CBQV vs PEGINTRON PEGFILGRASTIM-CBQV vs PEGLOTICASE PEGFILGRASTIM-CBQV vs PEGUNIGALSIDASE ALFA-IWXJ

Official FDA Label for PEGFILGRASTIM-CBQV

Official prescribing information from the FDA-approved drug label.